159P COM701 in combination with nivolumab demonstrates preliminary antitumor activity in patients with platinum-resistant epithelial ovarian cancer

Saved in:
Bibliographic Details
Published inImmuno-oncology technology Vol. 16; p. 100271
Main Authors Yeku, O., D. Shepard, Patel, M., Fleming, G., Vaena, D., Rasco, D., Chmielowski, B., Sharma, M.R., Hamilton, E., Sullivan, R.J., Papadopoulos, K., Izar, B., Cojocaru, G., Ophir, E., Ferre, P.J., Dumbrava, E.E.
Format Journal Article
LanguageEnglish
Published 01.12.2022
Online AccessGet full text

Cover

More Information
ISSN:2590-0188
2590-0188
DOI:10.1016/j.iotech.2022.100271